NuCana Provides Update on Impact of COVID-19 on Clinical Studies
(WorldNews Business)

EDINBURGH, United Kingdom, April 02, 2020 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) has been closely monitoring the potential impact of the COVID-19 pandemic on its operations and announced today an update on the status of its ongoing clinical studies. In order to help to protect the health of patients and investigators at its clinical study sites, the enrollment of new patients in its ongoing clinical studies has been temporarily paused. Patients who are currently enrolled in NuCana´s ongoing studies are continuing to receive treatment. `This pandemic has dramatically impacted the global healthcare delivery system and altered the landscape not only for NuCana, but also for the wider...